Induction Chemotherapy Plus Concurrent Chemoradiation Therapy (ICCRT) Versus Concurrent Chemoradiation Therapy (CRT) in the Treatment of Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Chang, J. [1 ]
Moon, S. [2 ]
Cho, K. [2 ]
Kim, T. [2 ]
Kim, H. [1 ]
Wu, H. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Res Inst & Hosp, Natl Canc Ctr, Proton Therapy Ctr, Gyeonggi Do, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.1472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S552 / S552
页数：1
相关论文
共 50 条
  • [31] Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer The Phase 2 KEYNOTE-799 Nonrandomized Trial
    Jabbour, Salma K.
    Lee, Ki Hyeong
    Frost, Nikolaj
    Breder, Valeriy
    Kowalski, Dariusz M.
    Pollock, Theodore
    Levchenko, Evgeny
    Reguart, Noemi
    Martinez-Marti, Alex
    Houghton, Baerin
    Paoli, Jean-Baptiste
    Safina, Sufia
    Park, Keunchil
    Komiya, Takefumi
    Sanford, Amy
    Boolell, Vishal
    Liu, Hong
    Samkari, Ayman
    Keller, Steven M.
    Reck, Martin
    JAMA ONCOLOGY, 2021, 7 (09) : 1351 - 1359
  • [32] Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer
    Iranzo, Vega
    Bremnes, Roy M.
    Almendros, Piedad
    Gavila, Joaquin
    Blasco, Ana
    Sirera, Rafael
    Camps, Carlos
    LUNG CANCER, 2009, 63 (01) : 63 - 67
  • [33] INTERIM RESULTS OF CONCURRENT CHEMORADIATION THERAPY WITH CONTINUOUS PACLITAXEL INFUSION AND WEEKLY CISPLATIN FOR STAGE III NON-SMALL CELL LUNG CANCER
    Lee, S. H.
    Chan, L. Kyu
    Jin-Ho, C.
    Kyung, C. Eun
    Hoon, P. Se
    Whan, J. Sung
    Woong, P. Jeong
    Soo-Jin, P.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S283 - S283
  • [34] Phase II multicentric study of concurrent chemoradiation i with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung cancer (NSCLC).
    Blanco, R
    Solé, J
    Nogué, M
    Montesinos, J
    Gallardo, E
    Vadell, C
    Mesía, C
    Algara, M
    Terrassa, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 696S - 696S
  • [35] Comparative Effectiveness of Neoadjuvant Chemoradiation Therapy Versus Chemotherapy Alone Followed by Surgery for Patients With Stage III Non-Small Cell Lung Cancer (NSCLC)
    Sher, D. J.
    Fidler, M.
    Liptay, M. J.
    Koshy, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S55 - S55
  • [36] Comparative Effectiveness of Neoadjuvant Chemoradiation Therapy Versus Chemotherapy Alone Followed by Surgery for Patients With Stage III Non-small Cell Lung Cancer (NSCLC)
    Sher, D. J.
    Fidler, M.
    Liptay, M. J.
    Koshy, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S145 - S146
  • [37] Results of Proton Beam Therapy without Concurrent Chemotherapy for Patients with Unresectable Stage III Non-small Cell Lung Cancer
    Oshiro, Yoshiko
    Mizumoto, Masashi
    Okumura, Toshiyuki
    Hashimoto, Takayuki
    Fukumitsu, Nobuyoshi
    Ohkawa, Ayako
    Kanemoto, Ayae
    Hashii, Haruko
    Ohno, Toshiki
    Sakae, Takeji
    Tsuboi, Koji
    Sakurai, Hideyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) : 370 - 375
  • [38] Phase II study of induction docetaxel/cisplatin followed by concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer (NSCLC)
    Pandya, Kishan J.
    Chen, Yuhchyau
    Hyrien, Ollieier
    Smudzin, Therese
    ANNALS OF ONCOLOGY, 2006, 17 : 229 - 229
  • [39] Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
    Nam, Jung Hyun
    Yeo, Chang Dong
    Park, Chan Kwon
    Kim, Sung Kyoung
    Kim, Ju Sang
    Kim, Yong Hyun
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    Kang, Hye Seon
    THORACIC CANCER, 2023, 14 (26) : 2657 - 2664
  • [40] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
12345